Corey Ritter
ARCH Venture Partners
Greater Chicago Area
Overview
Work Experience
Board Member
2025 - Current
Partner
2017
ARCH creates and invests in companies commercializing disruptive life and physical science technologies.
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Board Member
2021
Superconducting quantum computing. Pursuing fault-tolerance by solving the most important problem in quantum computing: error correction.
Quantum Circuits is developing and commercializing quantum computing technology that utilizes superconducting quantum circuits.
Raised $78,000,000.00 from F-Prime Capital, Tribeca Venture Partners, Fitz Gate Ventures, Hither Creek Ventures, Canaan Partners, Sequoia Capital, ARCH Venture Partners, IQT, Connecticut Innovations and OUP (Osage University Partners).
Board Member
2021
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Raised $49,227,275.00 from Northpond Ventures, Anterra Capital, ARCH Venture Partners, Northpond Ventures, ARCH Venture Partners and Anterra Capital.
Board Member
2022
Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.
Raised $123,500,000.00 from Venture Investors, TAO Investments, State of Wisconsin Investment Board, WARF Ventures, Sands Capital Ventures, ARCH Venture Partners, Northpond Ventures and Moore Strategic Ventures.
Board Member
2024
Board Observer
2019
Company creation, founding; led Series A financing.
Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.
Raised $136,200,000.00 from ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.
Board Observer
2019
Company creation, founding; led Series A financing.
Scale Biosciences is a single-cell profiling and analysis solutions company for genomic, transcriptomic, and multi-omic applications.
Board Observer
2018 - 2021
NASDAQ: MASS
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Raised $167,800,000.00 from Northpond Ventures, Saudi Aramco Energy Ventures, Razor's Edge Ventures, Tao Capital Partners, Casdin Capital, SLB, Sands Capital Ventures and ArchVentures SA.
George Schultz Innovation Fund Associate
2017 - 2017
The Innovation Fund invests in science-based startups emanating from U Chicago & Argonne National Lab.